Health & Peptide Science
Peptide reference
Structured reference entries covering sequence, mechanism, pharmacokinetics, and handling for compounds commonly cited in preclinical work.
41 compounds
Modified fragment of the C-terminal end of human growth hormone. Promotes lipolysis without the anabolic effects or impact on glucose of full GH.
15-amino acid peptide derived from gastric BPC binding protein. It accelerates the healing of tissues, tendons, and muscles.
Long-acting analog of amylin in advanced clinical development. In combination with semaglutide (CagriSema), it demonstrates up to 25% weight loss in clinical trials.
A mixture of neurotrophic peptides derived from porcine brain. Approved in several countries for the research into Alzheimer's disease and stroke. It mimics the effects of NGF and BDNF.
A long-acting GHRH analog that elevates baseline levels of GH and IGF-1 for several days. Frequently combined with Ipamorelin for synergistic effects.
Nootropic peptide considered millions of times more potent than BDNF for promoting neuronal synapse. Significantly enhances memory and learning in Alzheimer models.
Neuropeptide that induces delta sleep (deep slow-wave sleep). It enhances sleep quality, reduces stress, and possesses analgesic and antidepressant properties.
Tetrapeptide derived from the pineal gland with potent effects in cellular longevity models. It activates telomerase to elongate telomeres and restore immune and neuroendocrine function.
Myostatin antagonist protein that suppresses its activity, releasing the biological brake on muscle growth. Associated with dramatic gains in muscle mass.
Growth differentiation factor with systemic rejuvenation effects. Involved in the reversal of cardiac and cerebral aging in parabiosis studies.
Natural tripeptide with copper ion that possesses powerful skin regenerative properties, DNA repair capabilities, and effects in cellular longevity models. It stimulates the synthesis of collagen and elastin.
Second-generation GH Secretagogue with a potent stimulating effect on the pituitary. Significantly elevates cortisol and prolactin in addition to GH.
One of the first synthetic GH secretagogues. It strongly stimulates appetite and GH release, with widespread use in bodybuilding and recovery.
Endogenous incretin that regulates postprandial glucose and satiety. The molecular basis of drugs such as semaglutide and liraglutide, which have a very short half-life in their native form.
Synthetic gonadotropin-releasing hormone. It stimulates the pituitary gland to release LH and FSH, maintaining testicular function during exogenous testosterone research models.
High-potency GH Secretagogue with additional cardioprotective effects. It is one of the most potent GHRPs in stimulating GH release.
Stabilized fragment of the C-terminal end of human GH (amino acids 176–191). It promotes fat burning without raising glucose levels or inducing tissue growth.
Mitochondrial peptide of 21 amino acids with potent neuroprotective and effects in cellular longevity models. It protects against beta-amyloid-induced apoptosis and enhances insulin sensitivity.
Long-acting variant of human IGF-1 with 13 additional amino acids at the N-terminal. A potent promoter of muscle growth with low affinity for IGF-binding proteins.
Selective growth hormone secretagogue that stimulates the pituitary with minimal side effects. Considered one of the cleanest GHRPs available.
Neuropeptide that regulates the hypothalamic-pituitary-gonadal axis. It stimulates the release of GnRH and LH, promoting the production of testosterone and sex hormones.
Tripeptide derived from the C-terminal end of α-MSH. A potent intestinal anti-inflammatory agent with promising effects in IBD (inflammatory bowel disease).
Human antimicrobial peptide with potent immunomodulatory properties. It combats bacterial, viral, and fungal infections, and modulates the inflammatory response.
Synthetic analog of the melanocyte-stimulating hormone (α-MSH). Promotes skin tanning, reduces appetite, and enhances sexual function.
Isoform of IGF-1 produced locally in muscle in response to mechanical damage. It activates muscle satellite cells to promote repair and hypertrophy.
Mitochondrial peptide that regulates cellular energy metabolism. It enhances insulin sensitivity, increases exercise endurance, and activates longevity pathways.
Fundamental coenzyme of cellular metabolism that decreases with age. Supplementation with NAD+ enhances mitochondrial function, activates sirtuins, and serves as a foundation for cellular longevity research.
Antidepressant peptide derived from the TREK-1 channel. It demonstrates rapid antidepressant effects (within hours) in preclinical models, with the potential to overcome the limitations of current antidepressants.
Neuroprotective tripeptide derived from the pineal gland. Enhances memory, sleep, and has protective effects on the aging brain.
Melanocortin peptide approved by the FDA for female sexual dysfunction. It acts directly on the central nervous system to enhance sexual desire in both men and women.
Triple agonist GIP/GLP-1/Glucagon, the most advanced in its class. In phase 2 trials, it achieved up to 24% weight loss, surpassing semaglutide and tirzepatide.
Synthetic anxiolytic peptide derived from tuftsin. It reduces anxiety and enhances cognitive function without the sedative or addictive effects associated with benzodiazepines.
Long-acting GLP-1 analog approved for type 2 diabetes and obesity. It induces significant weight loss by reducing appetite and delaying gastric emptying.
Neuroprotective peptide derived from ACTH. It enhances memory, concentration, and brain function, with well-documented antidepressant and neuroprotective effects.
Biologically active fragment of natural GHRH. It physiologically stimulates the pituitary gland to produce GH, with a very favorable safety profile.
Octapeptide analog of the N-terminal end of SNAP-25 that inhibits the release of acetylcholine at the neuromuscular junction. Reduces expression wrinkles topically.
Cardiolipin-targeted peptide that protects mitochondrial function. It reduces oxidative stress, enhances ATP production, and has protective effects in cardiovascular and renal diseases.
Synthetic peptide derived from thymosin beta-4, a natural protein found in nearly all cells. A potent agent for muscle recovery and tissue repair.
FDA-approved GHRH analog for the reduction of visceral abdominal fat in clinical populations with HIV. Potent and effective for central fat reduction.
Thymic peptide approved in over 70 countries for chronic infections and cancer. It enhances the cellular immune response and modulates regulatory T cells.
Dual agonist GIP/GLP-1 approved. It surpasses simple GLP-1s in weight loss efficacy, with up to 22% reduction in body weight in clinical studies.
This material is published for scientific and educational reference. It is not medical advice, not a treatment recommendation, and not an offer to sell. Compounds discussed are for research and laboratory use only.